Shares of Symbiotec Pharmalab are set to debut on the BSE and NSE on Tuesday, with sentiment in the grey market remaining positive. The company’s shares are currently commanding a grey market premium (GMP) of 19%, indicating expectations of a decent listing gain over the IPO issue price. The Rs 1,757 crore public issue was priced at Rs 988 per share.

Symbiotec Pharmalab IPO has entered its final bidding day with the issue subscribed 5.31 times and the grey market premium indicating a potential 29% listing gain over the upper price band.

Hy-Tech Engineers is leading the three IPOs in grey market premium terms after Day 3, with an implied 75.47% listing gain, ahead of Symbiotec Pharmalab and Skyways Air Services.

Hy-Tech Engineers leads Symbiotec Pharmalab and Skyways Air on GMP and subscription demand. Check the latest GMP, listing gains and IPO details.

Three IPOs — Skyways Air Services, Symbiotec Pharmalab and Hy-Tech Engineers — will be closing today (August 27).

Symbiotec Pharmalab IPO: Check price band, GMP, open and close dates, lot size, allotment, listing date, financials and key IPO details.

ET Intelligence Group: Symbiotec Pharmalab plans to raise ₹150 crore through a fresh issue to repay debt and ₹1,607 crore through an offer for sale. The promoter group's stake will fall to 33.3% after the IPO from 36.4%. The company is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and specialty products. Over two-third of the revenue comes from international markets with Europe contributing nearly 30%.

New Delhi, India — The Indian IPO market is set for another busy week, with nine public issues scheduled to open and eight companies lined up for stock-market listings, according to the supplied market schedule. The upcoming IPOs include Hy-Tech Engineers, Skyways Air and Symbiotec Pharmalab, while the broader primary-market activity comes as Indian equities ended lower for a second consecutive week.

Securities and Exchange Board of India approved IPOs of six companies, including Vishvaraj Environment and SAEL Industries. Firms span sectors like renewable energy, chemicals and SaaS, while Jindal Supreme withdrew its draft papers, reflecting active primary market momentum.

Join Shoko Science at the upcoming PharmaLab EXPO 2026 to explore cutting-edge solutions for pharmaceutical research and development.

Torch Inc. showcases its innovative lab automation systems at PharmaLab EXPO Tokyo, aiming to revolutionize research development practices.

Enhance your work processes with a vacuum oven. Explore its advantages, applications, and maintenance tips to ensure optimal performance.

Inner Compass Initiative provides information and resources that help people make more informed choices regarding all things “mental health”.

Deprescribing.org - reducing medications safely to meet life’s changes. Online resources for clinicians and patients to help with deprescribing.

The pharmaceutical laboratory meeting adds sessions on AI in labs, and quality in biologics, mRNA and analytics.